FDA Inspection

Dana-Farber Cancer Institute, Office of Human Research Studies IRBFebruary 23, 2023

FDA Inspection 1201325 - Dana-Farber Cancer Institute, Office of Human Research Studies IRB - February 23, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Dana-Farber Cancer Institute, Office of Human Research Studies IRB, with an inspection on February 23, 2023, covering biologics.

Company: Dana-Farber Cancer Institute, Office of Human Research Studies IRB
Inspection Date: February 23, 2023
Product Type: Biologics

Open in Dashboard

ID · c7fa9014-b864-4174-ba96-65a88d76556b